RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.00
-0.46 (-5.44%)
At close: Jul 11, 2025, 4:00 PM
8.04
+0.04 (0.50%)
After-hours: Jul 11, 2025, 7:22 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $325.10 million as of July 11, 2025. Its market cap has decreased by -85.15% in one year.
Market Cap
325.10M
Enterprise Value
107.80M
1-Year Change
-85.15%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $325.10M, a decrease of -23.39%. That is a compound annual growth rate of -6.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 325.10M | -76.54% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |